Our integrative transcriptomic analysis of H. pylori–associated gastric cancer has identified hub genes such as CXCL1, CCL20, IL12B, and TPX2 as promising biomarkers and therapeutic targets, providing valuable insights into the molecular mechanisms linking H. pylori infection to gastric carcinogenesis. This evidence concerns the gene CXCL1 and gastric cancer.